As the foundation of our identification and antibiotic susceptibility testing (ID/AST) products, Conventional panels deliver accuracy, choice, and flexibility. With the fewest FDA limitations of leading automated ID/AST systems, use of conventional panels reduces supplemental testing costs and reporting delays associated with rapid only systems.

  • Direct minimum inhibitory concentration (MIC) susceptibility methodology helps ensure detection of emerging and low-level resistance, while combo ID/AST formats provide creative workflow solutions.
  • Our exclusive, PROMPT™ inoculation method with 4-hour stability reduces inoculum preparation time by over 40% when compared to turbidity methods.